通过MicroED确定了Mirabegron的不同形状
Jieye Lin1, Johan Unge1, Tamir Gonen1,2,3
1Department of Biological Chemistry, University of California, 615 Charles E. Young Drive South, Los Angeles, CA, 90095, USA.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|October 17, 2023
概括
治疗过度活动膀的药物Mirabegron使用MicroED揭示了它的3D结构和两个不同的形式. 药物在与其受体结合时经历了显著的形状变化.
科学领域:
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
- 晶体学 晶体学是指结晶学.
背景情况:
- 米拉贝格朗 (Myrbetriq) 是一种广泛用于治疗过度活动膀综合征的药物.
- 米拉贝格朗在受体结合时的三维 (3D) 结构和构造行为以前是未知的.
研究的目的:
- 为了阐明米拉贝格朗的3D结构.
- 为了研究Mirabegron的形状状态.
- 了解Mirabegron在与β3上腺素受体 (β3AR) 结合时的形状变化.
主要方法:
- 微晶电子衍射 (MicroED) 被用来确定Mirabegron的结构.
- 对结合和晶体包装的分析.
- 单独比较Mirabegron的结构和与β3AR结合的结构.
主要成果:
- 发现Mirabegron采用了两个不同的构造状态 (构造者).
- 水友性群体嵌入晶格,导致疏水表面和低水溶性.
- 符合1和2的表现分别是变形和形,Mirabegron经历了主要的结构变化来结合β3AR.
结论:
- 微ED对于从粉末中确定未知和多态结构的活性药物成分 (API) 有效.
- 这项研究揭示了Mirabegron特性及其与β3AR的相互作用的结构基础.
- 了解这些结构细节可以为未来的药物设计和开发提供信息.
更多相关视频
相关概念视频
Conformations of Butane
14.3K
Unlike ethane and propane that have only two major conformations, butane has more than two conformers. The staggered form of butane in which the bulky methyl groups on the two carbons are placed on opposite sides, that is, at a dihedral angle of 180°, is the lowest energy, most stable form — called the anti conformer. This conformation is stabilized due to the absence of steric repulsion between the largely spaced out methyl groups. The other two staggered conformations are...
14.3K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
272
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
272
Cholinergic Antagonists: Pharmacokinetics
497
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
497
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
589
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
589


